Expertise in
8
conditions

Venkatraman S. Radhakrishnan

38, Sardar Patel Road, 
Chennai, TN, IN 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
8
conditions
38, Sardar Patel Road, 
Chennai, TN, IN 

Overview

Venkatraman Radhakrishnan practices practicing medicine in Chennai, India.

Radhakrishnan is highly rated in 8 conditions, according to our data. Their clinical expertise encompasses Febrile Neutropenia, Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Nephrectomy, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 141 peer reviewed articles and participating in 2 clinical trials.

Locations

38, Sardar Patel Road, Chennai, TN 600036, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2b Open-label Study of Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
A Phase 2b Open-label Study of Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Enrollment Status: Recruiting
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Selinexor
Study Phase: Phase 2
A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drugs: Selinexor, Bortezomib, Dexamethasone
Study Phase: Phase 3
View 1 Less Clinical Trial

141 Total Publications

Primary uterine yolk sac tumour: a rare and aggressive malignancy - navigating diagnostic uncertainty and treatment pathway.
Primary uterine yolk sac tumour: a rare and aggressive malignancy - navigating diagnostic uncertainty and treatment pathway.
Journal: BMJ case reports
Published: February 04, 2026

Frequently Asked Questions about Venkatraman S. Radhakrishnan

Is Venkatraman S. Radhakrishnan a top-rated expert for Febrile Neutropenia?

MediFind is an objective health platform that identifies experts based on real-world data. Venkatraman S. Radhakrishnan is classified as an Advanced expert for Febrile Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Venkatraman S. Radhakrishnan participate in research or clinical trials?

Yes. Venkatraman S. Radhakrishnan has published 141 articles and abstracts on conditions like Febrile Neutropenia. You can view a list of Venkatraman S. Radhakrishnan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Radhakrishnan's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 39 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile